Skip to main content
Premium Trial:

Request an Annual Quote

Reagents Applera, Promega Settle; Details Remain Confidential

Premium

Facing a fast-approaching trial thanks to Wisconsin’s accelerated court system, the so-called “rocket docket,” Applera and Promega have settled their reagent-based patent infringement suits against each other.

According to Don Best, attorney for Promega, the settlement was entered and the case dismissed by the end of October. One of the patents at issue was the one of the three automated DNA sequencer patents that has been charged as illegitimate in an unrelated MJ Research suit against Applera, which was reason enough for the industry to watch the outcome of the Promega suit with interest.

The settlement came at the eleventh hour for both sides. “When you’re a month away [from trial], it gets pretty intense,” Best says. “Both parties end up doing a ton of work, as you might expect, to get a case of this magnitude and complexity … ready for trial.”

Though the confidentiality details of the settlement have not yet been determined, each side is acting as though all aspects of the agreement are top-secret, Best says. No doubt their silence will simply add fuel to the rumors that will certainly be making the industry rounds on who the “victor” was.

 

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.